Belite Bio, Inc (BLTE) stock

BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 5/30

$169.96+14.02 (+8.99%)

Close on Nov 12, 2026Market cap $6.69BP/E –Yield –

Belite Bio EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Belite Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?